[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586454":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":34,"collaborators":36,"id":41,"slug":7,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":42,"sex":47,"minAge":48,"maxAge":7,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"IRCCS San Raffaele Roma","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Lucia Gatta, PhD","CONTACT","+390652253440","lucia.gatta@sanraffaele.it",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":20,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"IRCCs San Raffaele","RECRUITING","Rome","RM","00166","Italy","IT",{"type":24,"coordinates":25},"Point",[26,27],12.51133,41.89193,{"lat":27,"lon":26},[30],{"name":31,"role":11,"phone":32,"phoneExt":7,"email":33},"Prof. Maurizio Volterrani, MD","0652253440","maurizio.volterrani@sanraffaele.it",{"type":35,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[37,39],{"name":38,"class":6},"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari",{"name":40,"class":6},"Azienda Ospedaliera Universitaria Mater Domini, Catanzaro","100586454",false,"NCT06915584","Drug Management in Heart Failure","DRUM-HF","Inclusion Criteria:\n\n* Both gender\n* Age \\>18 years\n* Signed informed consent for the study\n* Known diagnosis of heart failure \\> 6 months\n* Recent or ongoing hospitalization for heart failure exacerbation\n\nExclusion Criteria:\n\n* Conditions that, in the investigator's judgment, may interfere with the study or contraindicate participation for safety reasons\n* Concurrent diagnosis of neoplasia\n* Advanced COPD (FEV1 \\\u003C50%)\n* Advanced valvular heart disease (severe mitral-aortic stenosis-insufficiency requiring cardiac surgery)","ALL","18 Years",{"count":50,"type":51},450,"ESTIMATED","OBSERVATIONAL","Aim of the proposal is to create an interactive AI-based multicentre prospective database to provide information on how to improve the QoC for pts with HF.This will provide detailed information on pts characteristics,treatment practices, adherence to prescribed guideline-based optimal drug therapy,and outcomes.The database stems from a registry started two years ago,conceived to provide a contemporary snapshot on the adherence to the latest European GGLL for the therapeutic management of pts with HF.The database will be integrated with a specifically designed algorithm that provides an accurate feedback on whether patients are properly treated according to the ESC most recent recommendations.The expected outcomes are:-define non-adherence level to GGLL-based recommendations for treatment of HF;-provide information on initiation, adherence and persistence over time of the recommended treatment;-reduce medical inertia;produce practical implications to reduce morbidity and mortality",[55],"Heart Failure",[55,57,58,59],"Descriptive appropriateness","Registry","Digital therapy","2025-03-31",{"date":62,"type":63},"2025-04-08","ACTUAL",{"date":65,"type":63},"2024-11-30",{"date":67,"type":51},"2025-08-31",{"name":5,"class":6},1]